Breaking News

Lilly CEO Returns

By Gil Roth | July 8, 2013

Lechleiter makes recovery from heart surgery

John C. Lechleiter, Ph.D., has returned to his duties as chairman, president, and chief executive officer of Eli Lilly & Co. Dr. Lechleiter has been on medical leave since his scheduled surgery for a dilated aorta on May 13, 2013. His surgery and recovery were successful and he has been cleared by his personal physician and the company's employee health services physician to return to full-time work.

"I am overwhelmed and humbled by the tremendous support and well-wishes I have received from my friends and fellow Lilly colleagues around the world," Dr. Lechleiter said. "I return to Lilly with renewed energy and enthusiasm, along with a new perspective on health and wellness and the critical importance of new medicines in advancing patient care.

"I want to thank and acknowledge Derica Rice for the important role he played during my absence, as well as Ellen Marram for her leadership of the Lilly board," he added.

Derica W. Rice will continue in his role as executive vice president, global services and chief financial officer. Mr. Rice had assumed the additional role of acting chief executive officer during Dr. Lechleiter's medical leave. Ellen R. Marram will continue in her role as the board's lead independent director after serving as acting chairperson of the board during that time.
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus